Ventripoint Diagnostics Ltd. (VPTDF)
OTCMKTS
· Delayed Price · Currency is USD
0.0919
+0.0030 (3.26%)
May 23, 2025, 3:13 PM EDT
Ventripoint Diagnostics Revenue
In the year 2024, Ventripoint Diagnostics had annual revenue of 95.17K CAD with 93.51% growth.
Revenue
95.17K CAD
Revenue Growth
+93.51%
P/S Ratio
215.15
Revenue / Employee
n/a
Employees
n/a
Market Cap
14.23M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
| BioStem Technologies | 332.45M |
Ventripoint Diagnostics News
- 24 days ago - Ventripoint Expands Advisory Board with addition of Ultrasound AI Executive - TheNewswire
- 6 weeks ago - Ventripoint Provides Corporate Update and Announces Shareholder Teleconference - TheNewswire
- 6 weeks ago - Ventripoint Appoints Nicolas Coutin to Oversee Clinical Affairs - TheNewswire
- 7 weeks ago - Ventripoint Makes Application to Amend Warrants - TheNewswire
- 2 months ago - Ventripoint Diagnostics Publishes Whitepaper on the Use of AI in Whole-Heart Analysis - TheNewswire
- 2 months ago - Ventripoint Announces Closing of $500,000 Non-Brokered Convertible Debenture Unit Private Placement - TheNewswire
- 2 months ago - Ventripoint Announces Non-Brokered Convertible Debenture Units Private Placement - TheNewswire
- 3 months ago - Ventripoint Diagnostics Announces U.S. FDA 510(k) Clearance for VMS+(TM) 4.0 Automated Radiological Image Processing Software/System - TheNewswire